Stock Analiz

SNDL Inc. SNDL

Medicinal Chemicals and Botanical Products · IPO 2019 · data as of November 13, 2026

$1.37Market cap $333M
Open the interactive analysis →

SNDL Inc. (SNDL) is a healthcare company listed in the US with a market value of about $333M. In the twelve months to September 30, 2026 it had revenue of $646M and net income of -$41M, a net margin of -6.4%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (1/5).

Key numbers: a price to free cash flow of 11.5, 5-year revenue growth of 71% a year, a 5-year average ROIC of -9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 66% below the current price.

About SNDL

SNDL is listed in the US and classified in medicinal chemicals and botanical products, IPO year 2019. Revenue went from $49M in 2019 to $691M in 2025, growth of about 55.5% a year. It was profitable in 0 of the last 8 years in our data.

Score: 1.6 / 5

Value1/5
Future growth1/5
Track record1/5
Financial health3/5
Shareholder returns2/5

Checks passed

  • P/FCF below 20
  • Profit margin improving
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Positive free cash flow
  • Liabilities below 60% of assets
  • 20% to 100% of free cash flow returned to shareholders
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E45.7
P/FCF11.5
P/S0.5
P/B0.5
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield8.7%
Shareholder yield3.4%
Intrinsic value vs. price−66%

Growth and quality

Revenue growth (1 yr)8.1%
Revenue growth (5 yrs, per year)70.6%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-96.5%
ROIC (5-yr avg.)-9.5%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 8 years

Fiscal yearTTM20252024202320222021202020192018
Revenue$646M$691M$640M$686M$526M$44M$48M$49M—
Net income-$41M-$12M-$66M-$130M-$248M-$179M-$183M-$209M-$10M
Free cash flow$29M$42M$32M-$18M-$13M-$126M-$48M-$172M-$10M
EPS (diluted)$-0.16$-0.05$-0.27$-0.54$-1.02$-0.73$-0.75$-0.86$-0.04
Net margin-6.4%-1.7%-10.3%-19.0%-47.0%-404.4%-382.9%-427.1%—
ROIC—-0.5%-7.2%-10.6%-21.0%-8.0%-53.9%-10.5%-49.1%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is SNDL stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 66% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does SNDL pay a dividend?

Not currently.

Is SNDL a good stock to buy?

We do not give buy or sell advice. SNDL scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.